In CA-CRC, FOXP3+ Tregs suppress the immune system’s ability to fight cancer, while IL-17-producing Th17 cells promote the growth of epithelial cells, the formation of blood vessels, and cell resistance to death. Here, FOXP3 is linked to cancer.